Screener
Collegium Pharmaceutical, Inc. COLL Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Collegium Pharmaceutical, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:34 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053851
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Accrued liabilities | 8,123 | (12,086) |
| Accrued rebates, returns and discounts | 7,303 | (8,239) |
| Deferred revenue | (333) | — |
| Net cash provided by operating activities | 128,436 | 127,837 |
| Investing activities | ||
| Acquisition of Azstarys (net of cash acquired) | (655,403) | — |
| Purchases of property and equipment | (766) | (863) |
| Purchases of marketable securities | (20,100) | (42,501) |
Item 1. Condensed Consolidated Financial Statements (Unaudited).
FAQ
- What is Collegium Pharmaceutical, Inc.'s operating cash flow?
- Collegium Pharmaceutical, Inc. (COLL) reported operating cash flow of $71.32M in Q2 2026.
- How has Collegium Pharmaceutical, Inc.'s operating cash flow changed year-over-year?
- Collegium Pharmaceutical, Inc.'s operating cash flow decreased by 1.5% year-over-year, from $72.44M to $71.32M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s operating cash flow?
- Over 4 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s operating cash flow has grown at a 33.5% compound annual growth rate (CAGR), from $103.56M to $329.32M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Collegium Pharmaceutical, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude